BioSpace News Archive

Press Releases

Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases

June 29, 2026
·
17 min read
Press Releases

Viatris Announces Positive Top-Line Results from Phase 3 Study of VR-205 in Japanese Adults with Primary Immunoglobulin A Nephropathy

June 29, 2026
·
9 min read
Press Releases

Neurogene Reports Positive Long-term Clinical Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome

June 29, 2026
·
10 min read
Press Releases

Precision BioSciences Announces Inclusion in the Russell 2000® Index Expanding Market Visibility with Institutional Investors

June 29, 2026
·
7 min read
Press Releases

Helus Pharma Reports Recent Business Highlights and Fiscal Year 2026 Financial Results

June 29, 2026
·
15 min read
Press Releases

Xilio Therapeutics Appoints Ben Harshbarger as Chief Legal Officer

June 29, 2026
·
5 min read
Press Releases

Kailera Therapeutics Appoints Kathleen Tregoning as Chief Corporate Affairs Officer

June 29, 2026
·
5 min read
Press Releases

Palvella Therapeutics Submits First Module of Rolling New Drug Application to FDA for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations

June 29, 2026
·
9 min read
Press Releases

Genflow Biosciences PLC Announces Result of AGM

June 29, 2026
·
3 min read
Press Releases

Eisai to Showcase Alzheimer’s Disease Portfolio with More Than 50 Presentations at the Alzheimer’s Association International Conference® 2026 (AAIC®)

June 29, 2026
·
15 min read